Missing Links?: 1093   Citation Matrix Graphs Glossary  HistCite Guide  About
Wed Oct 5 14:33:16 2005
Publications by W Szybalski
and the papers citing W Szybalski

Nodes: 10146, Authors: 16970, Journals: 1137, Outer References: 208320, Words: 13772
Collection span: 1949 - 2005
View: Overview. Sorted by journal name. Page 21 of 102:  1   11  [  21  22  23  24  25  26  27  28  29  30 ]  31   41   51   61   71   81   91  |  101 

#LCRNCRNode / Date / Journal / AuthorLCSGCS
200119473 1962 CANADIAN JOURNAL OF MICROBIOLOGY 8 (6): 933-&
COOK FD; QUADLING C
PEROXIDE PRODUCTION BY RHIZOBIUM MELILOTI
04
2002119618 1963 CANADIAN JOURNAL OF MICROBIOLOGY 9 (2): 179-&
ALLEN WE; MCVEIGH I
GROWTH OF PENICILLIN-RESISTANT AND PENICILLIN-SENSITIVE STRAINS OF STAPHYLOCOCCUS AUREUS
00
2003113777 1964 CANADIAN JOURNAL OF MICROBIOLOGY 10 (2): 221-&
SCHWINGHAMER EA
ASSOCIATION BETWEEN ANTIBIOTIC RESISTANCE + INEFFECTIVENESS IN MUTANT STRAINS OF RHIZOBIUM SPP
049
2004326778 1964 CANADIAN JOURNAL OF MICROBIOLOGY 10 (4): 595-&
BOROWSKI J
DEVELOPMENT OF PENICILLIN-SENSITIVE MUTANTS IN COURSE OF NATURAL + EXPERIMENTAL INFECTION WITH PENICILLINASE-PRODUCING STAPHYLOCOCCUS AUREUS STRAINS
02
2005620973 1965 CANADIAN JOURNAL OF MICROBIOLOGY 11 (2): 185-&
MCCALLA DR
NITROFURAN DERIVATIVES AS RADIOMIMETIC AGENTS - CROSS-RESISTANCE STUDIES WITH ESCHERICHIA COLI
532
2006120974 1965 CANADIAN JOURNAL OF MICROBIOLOGY 11 (2): 213-&
BERK RS
EFFECT OF ANTIBACTERIAL AGENTS ON AUTOPLAQUE PHENOMENON OF PSEUDOMONAS AERUGINOSA
011
2007312975 1965 CANADIAN JOURNAL OF MICROBIOLOGY 11 (2): 393-&
VIENS P; SONEA S; DEREPENT.J
INHIBITION DE LACTION ANTIBACTERIENNE DE LA PENICILLINE CHEZ DES STAPHYLOCOQUES CULTIVES EN PRESENCE DORANGE DACRIDINE
00
20082281376 1967 CANADIAN JOURNAL OF MICROBIOLOGY 13 (1): 81-&
PERRON JM; SMIRNOFF WA; HUOT L
COMPARAISON DE TOXICITE DE QUELQUES ELEMENTS POUR BACILLUS THURINGIENSIS VAR THURINGIENSIS BERL
01
20095341572 1968 CANADIAN JOURNAL OF MICROBIOLOGY 14 (6): 667-&
YAMAMOTO T; CHOW CT
MITOMYCIN C INDUCTION OF A TEMPERATE PHAGE IN PSEUDOMONAS AERUGINOSA
415
20101271845 1969 CANADIAN JOURNAL OF MICROBIOLOGY 15 (4): 335-&
BOVRE K; FIANDT M; SZYBALSKI W
DNA BASE COMPOSITION OF NEISSERIA MORAXELLA AND ACINETOBACTER AS DETERMINED BY MEASUREMENT OF BUOYANT DENSITY IN CSCL GRADIENTS
3333
#LCRNCRNode / Date / Journal / AuthorLCSGCS
2011141846 1969 CANADIAN JOURNAL OF MICROBIOLOGY 15 (5): 489-&
HUNT DE; SANDHAM HJ
EFFECT OF ETHYLENEDIAMINETETRAACETIC ACID ON ACTINOBOLIN-RESISTANCE IN ESCHERICHIA COLI
13
20121171847 1969 CANADIAN JOURNAL OF MICROBIOLOGY 15 (9): 1067-&
AMIN AH; SUBBAIAH TV; ABBASI KM
BERBERINE SULFATE - ANTIMICROBIAL ACTIVITY, BIOASSAY, AND MODE OF ACTION
073
20131342124 1970 CANADIAN JOURNAL OF MICROBIOLOGY 16 (9): 801-&
COULTER WH; COSTILOW RN
ROLE OF BARBITURIC ACID IN NUTRITION OF BACILLUS-POPILLIAE
04
20141172125 1970 CANADIAN JOURNAL OF MICROBIOLOGY 16 (10): 973-&
BARABAS G; MEHTA BM; KUSHNER DJ
PROFLAVINE BINDING AND RELEASE BY SENSITIVE AND RESISTANT BACILLUS-SUBTILIS
03
20155142468 1971 CANADIAN JOURNAL OF MICROBIOLOGY 17 (1): 87-&
JONES RJ; HEWITT RR
EFFECT OF 5-BROMOURACIL ON GROWTH OF A THYMINE AUXOTROPH OF ESCHERICHIA-COLI K-12
12
20161282469 1971 CANADIAN JOURNAL OF MICROBIOLOGY 17 (12): 1491-&
LAMBERT MA; THOMAS ML; WEAVER RE; MOSS CW; HOLLIS DG
CELLULAR FATTY-ACIDS OF NONPATHOGENIC NEISSERIA
228
20173143186 1973 CANADIAN JOURNAL OF MICROBIOLOGY 19 (4): 531-533
LESLEY SM; BEHKI RM
SENSITIVITY TO MYXIN OF ESCHERICHIA-COLI TREATED WITH ETHYLENEDIAMINETETRAACETIC ACID
00
20187173903 1975 CANADIAN JOURNAL OF MICROBIOLOGY 21 (7): 1116-1120
PAI CH; YAU HC
CHROMOSOMAL LOCATION OF MUTATIONS AFFECTING REGULATION OF BIOTIN SYNTHESIS IN ESCHERICHIA-COLI
410
20197353904 1975 CANADIAN JOURNAL OF MICROBIOLOGY 21 (8): 1151-1159
FRANCIS MM; CELLA R; VINING IC
GENETIC RECOMBINATION IN A CHLORAMPHENICOL-PRODUCING STRAIN OF STREPTOMYCES SPECIES 3022A
211
20203123905 1975 CANADIAN JOURNAL OF MICROBIOLOGY 21 (10): 1484-1491
MCCALLA DR; OLIVE P; TU Y; FAN ML
NITROFURAZONE-REDUCING ENZYMES IN E-COLI AND THEIR ROLE IN DRUG ACTIVATION INVIVO
554
#LCRNCRNode / Date / Journal / AuthorLCSGCS
20214104266 1976 CANADIAN JOURNAL OF MICROBIOLOGY 22 (2): 301-303
CHOW CT
RESISTANCE OF THIOBACILLUS-NOVELLUS TO MITOMYCIN-C AND RIFAMPICIN
12
20221304267 1976 CANADIAN JOURNAL OF MICROBIOLOGY 22 (9): 1222-1228
WARDLEY RC; BABIUK LA; ROUSE BT
POLYMORPH-MEDIATED ANTIBODY-DEPENDENT CYTOTOXICITY-MODULATION OF ACTIVITY BY DRUGS AND IMMUNE INTERFERON
023
20231104268 1976 CANADIAN JOURNAL OF MICROBIOLOGY 22 (9): 1399-1401
JOBSON A; COOK FD; WESTLAKE DWS
BUOYANT DENSITY, CONVERSION FORMULAS, AND MOLE PERCENT GUANOSINE + CYTOSINE CONTENT OF DESULFOVIBRIO SP
00
20245214618 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (1): 45-51
WARNER FD; KITOS GA; ROMANO MP; HEMPHILL HE
CHARACTERIZATION OF SPBETA - TEMPERATE BACTERIOPHAGE FROM BACILLUS-SUBTILIS-168M
265
20253224619 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (4): 398-401
SAFE LM; SAFE SH; SUBDEN RE; MORRIS DC
STEROL CONTENT AND POLYENE ANTIBIOTIC-RESISTANCE IN ISOLATES OF CANDIDA-KRUSEI, CANDIDA-PARAKRUSEI, AND CANDIDA-TROPICALIS
149
20262124620 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (6): 751-754
SUBDEN RE; SAFE L; MORRIS DC; BROWN RG; SAFE S
EBURICOL, LICHESTEROL, ERGOSTEROL, AND OBTUSIFOLIOL FROM POLYENE ANTIBIOTIC-RESISTANT MUTANTS OF CANDIDA-ALBICANS
224
20272314621 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (9): 1123-1127
DEBETTE J; BLONDEAU R
CHARACTERIZATION OF TELLURIC BACTERIA WITH CLOSE AFFINITY TO PSEUDOMONAS-MALTOPHILIA
011
20283524622 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (10): 1415-1425
SKYRING GW; JONES HE; GOODCHILD D
TAXONOMY OF SOME NEW ISOLATES OF DISSIMILATORY SULFATE-REDUCING BACTERIA
026
20292234623 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (11): 1568-1572
TANENBAUM SW; FLASHNER M
ARTHROBACTER-SIALOPHILUS SP-NOV - NEURAMINIDASE-PRODUCING CORYNEFORM
09
20301114960 1978 CANADIAN JOURNAL OF MICROBIOLOGY 24 (12): 1619-1621
VANTASSELL RL; WILKINS TD
ISOLATION OF AUXOTROPHS OF BACTEROIDES-FRAGILIS
231
#LCRNCRNode / Date / Journal / AuthorLCSGCS
20313215267 1979 CANADIAN JOURNAL OF MICROBIOLOGY 25 (3): 291-297
RAPP BJ; KEMP JD; WHITE F
ISOLATION OF A NON-TUMOR-INDUCING MUTANT OF THE TI PLASMID OF AGROBACTERIUM-TUMEFACIENS STRAIN-B6
01
20328415268 1979 CANADIAN JOURNAL OF MICROBIOLOGY 25 (9): 1027-1035
COMPTON SW; MAYO JA; EHRLICH M; ACKERMANN HW; TREMBLAY L; et al.
DNA-BASE COMPOSITION, NATURE OF INTRACELLULAR DNA, MORPHOLOGY, AND CLASSIFICATION OF BACTERIOPHAGES INFECTING MICROCOCCUS-LUTEUS
14
20331515611 1980 CANADIAN JOURNAL OF MICROBIOLOGY 26 (8): 881-886
MCCLUNG CR; PATRIQUIN DG
ISOLATION OF A NITROGEN-FIXING CAMPYLOBACTER SPECIES FROM THE ROOTS OF SPARTINA-ALTERNIFLORA LOISEL
036
20341385612 1980 CANADIAN JOURNAL OF MICROBIOLOGY 26 (8): 938-951
MARTIN SM; ROGOLSKY M
DNA-MEDIATED TRANSFORMATION IN MUTANTS OF PHAGE GROUP 2 STAPHYLOCOCCUS-AUREUS
02
20354355940 1981 CANADIAN JOURNAL OF MICROBIOLOGY 27 (2): 175-183
TAYLOR DE; LEVINE JG; SIBAY G; WALTER A
GENETIC-STUDIES OF H-GROUP PLASMIDS BY BACTERIOPHAGE-P1 TRANSDUCTION
01
20364245941 1981 CANADIAN JOURNAL OF MICROBIOLOGY 27 (6): 616-626
KONARSKAKOZLOWSKA M; IYER VN
THE GENETIC AND PHYSICAL BASIS OF VARIABILITY IN ESCHERICHIA-COLI STRAINS CARRYING A REFERENCE INC N-GROUP PLASMID
014
20372116291 1982 CANADIAN JOURNAL OF MICROBIOLOGY 28 (1): 141-144
DHILLON TS; DHILLON EKS; LINN S
RESTRICTION FRAGMENT ANALYSIS FOR DIFFERENTIATION OF INDISTINGUISHABLE TEMPERATE COLIPHAGES
02
20386246292 1982 CANADIAN JOURNAL OF MICROBIOLOGY 28 (4): 406-413
BAHARAEEN S; BANTLE JA; VISHNIAC HS
THE EVOLUTION OF ANTARCTIC YEASTS - DNA-BASE COMPOSITION AND DNA-DNA HOMOLOGY
015
20391226934 1984 CANADIAN JOURNAL OF MICROBIOLOGY 30 (5): 682-690
FEIN JE; TALLIM SR; LAWFORD GR
EVALUATION OF D-XYLOSE FERMENTING YEASTS FOR UTILIZATION OF A WOOD-DERIVED HEMICELLULOSE HYDROLYSATE
032
20406257872 1988 CANADIAN JOURNAL OF MICROBIOLOGY 34 (12): 1288-1296
NATH SK
ATTENUATION OF TRANSCRIPTION OF BIOTIN GENES IN ESCHERICHIA-COLI
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
20417229947 2003 CANADIAN JOURNAL OF MICROBIOLOGY 49 (3): 225-229
Slavcev RA; Bull HJ; Hayes S
Bacteriophage lambda repressor allelic modulation of the Rex exclusion phenotype
11
2042226010102 2005 CANADIAN JOURNAL OF MICROBIOLOGY 51 (1): 37-49
Hayes S; Slavcev R
Polarity within p(M) and p(E) promoted phage lambda cl-rexA-rexB transcription and its suppression
00
20439163906 1975 CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE 10 (2): 271-276
WILSON FM; SMOLIN G; OKUMOTO M
THERAPY OF EXPERIMENTAL HERPETIC KERATITIS WITH IDU AND FLUORESCENT LIGHT - NEGATIVE STUDY
00
20441338285 1990 CANADIAN JOURNAL OF SURGERY 33 (4): 265-270
WEBBER EM; MACFARLANE JK
PREOPERATIVE RADIOTHERAPY FOR ADENOCARCINOMA OF THE RECTUM
01
204531361175 1966 CANADIAN MEDICAL ASSOCIATION JOURNAL 94 (1): 23-&
LARKE RPB
INTERFERON - A CHANGING PICTURE
012
2046416619 1963 CANCER 16 (3): 355-&
FLETCHER GH; SUIT HD; HOWE CD; SAMUELS M; VILLAREAL RU; et al.
CLINICAL METHOD OF TESTING RADIATION-SENSITIZING AGENTS IN SQUAMOUS CELL CARCINOMA
747
20472361176 1966 CANCER 19 (1): 103-&
BICKIS IJ; HENDERSO.IW; QUASTEL JH
BIOCHEMICAL STUDIES OF HUMAN TUMORS .2. IN VITRO ESTIMATION OF INDIVIDUAL TUMOR SENSITIVITY TO ANTICANCER AGENTS
169
20485271377 1967 CANCER 20 (1): 31-&
NASJLETI CE; SPENCER HH
CHROMOSOME POLYPLOIDIZATION IN HUMAN LEUKOCYTE CULTURES TREATED WITH STREPTONIGRIN AND CYCLOPHOSPHAMIDE
133
20493341378 1967 CANCER 20 (3): 333-&
TAN C; TASAKA H; YU KP; MURPHY ML; KARNOFSK.DA
DAUNOMYCIN AN ANTITUMOR ANTIBIOTIC IN TREATMENTT OF NEOPLASTIC DISEASE - CLINICAL EVALUATION WITH SPECIAL REFERENCE TO CHILDHOOD LEUKEMIA
21276
2050191981573 1968 CANCER 21 (1): 58-&
VERMUND H; GOLLIN FF
MECHANISMS OF ACTION OF RADIOTHERAPY AND CHEMOTHERAPEUTIC ADJUVANTS - A REVIEW
750
#LCRNCRNode / Date / Journal / AuthorLCSGCS
20511872126 1970 CANCER 26 (4): 737-&
HADDOW A
THOUGHTS ON CHEMICAL THERAPY
06
20522152804 1972 CANCER 29 (5): 1293-&
SUTOW WW; TALLEY RW; VIETTI TJ; LONSDALE D
DAUNOMYCIN IN TREATMENT OF METASTATIC SOFT-TISSUE SARCOMA IN CHILDREN
07
20533803907 1975 CANCER 35 (1): 111-120
BLOOM HJG
COMBINED MODALITY THERAPY FOR INTRACRANIAL TUMORS
1105
20541204269 1976 CANCER 37 (2): 1218-1225
HALL TC
LATE EFFECTS OF CANCER-THERAPY - ROLE OF CLINICAL PHARMACOLOGIST
01
20557644624 1977 CANCER 39 (2): 987-999
PHILLIPS TL
CHEMICAL MODIFICATION OF RADIATION EFFECTS
240
20563294961 1978 CANCER 41 (2): 403-414
MIYAMOTO T; TAKABE Y; WATANABE M; TERASIMA T
EFFECTIVENESS OF A SEQUENTIAL COMBINATION OF BLEOMYCIN AND MITOMYCIN-C ON AN ADVANCED CERVICAL-CANCER
375
2057172215942 1981 CANCER 47 (10): 2327-2345
MILLER EC; MILLER JA
SEARCHES FOR ULTIMATE CHEMICAL CARCINOGENS AND THEIR REACTIONS WITH CELLULAR MACROMOLECULES
6646
20582196293 1982 CANCER 49 (10): 1953-1957
MILSTEIN C
MONOCLONAL-ANTIBODIES
013
20593236596 1983 CANCER 51 (4): 600-605
MABEL JA; WODINSKY I
MITOMYCIN-C COMBINATION THERAPY AGAINST MURINE TUMOR SYSTEMS - EFFECTIVENESS WITH CYCLOPHOSPHAMIDE AND METHOTREXATE
01
20604526935 1984 CANCER 53 (10): 2034-2040
AMES BN
THE DETECTION OF ENVIRONMENTAL MUTAGENS AND POTENTIAL CARCINOGENS
012
#LCRNCRNode / Date / Journal / AuthorLCSGCS
206191397213 1985 CANCER 55 (9): 2037-2050
BRADY LW; MARKOE AM; SHELINE GE; SUNTHARALINGAM N; SUTHERLAND RM
RADIATION ONCOLOGY - PROGRAMS FOR THE PRESENT AND FUTURE
05
20628817214 1985 CANCER 56 (10): 2351-2363
ELKIND MM
DNA DAMAGE AND CELL KILLING - CAUSE AND EFFECT
048
206310297675 1987 CANCER 59 (5): 908-915
KINSELLA TJ; GLATSTEIN E
CLINICAL-EXPERIENCE WITH INTRAVENOUS RADIOSENSITIZERS IN UNRESECTABLE SARCOMAS
1840
20643287873 1988 CANCER 61 (9): 1741-1748
YOSHIDA H; OISHI Y; YANAGAWA T; YURA Y; AZUMA M; et al.
ENHANCEMENT OF CIS-DIAMMINEDICHLOROPLATINUM AND MITOMYCIN-C-INDUCED SISTER CHROMATID EXCHANGES BY DIBUTYRYL CYCLIC-AMP IN A HUMAN SALIVARY-GLAND ADENOCARCINOMA CELL-LINE IN CULTURE
05
206510367874 1988 CANCER 61 (12): 2433-2438
NAGASHIMA T; HOSHINO T; CHO KG; EDWARDS MSB; HUDGINS RJ; et al.
THE PROLIFERATIVE POTENTIAL OF HUMAN EPENDYMOMAS MEASURED BY INSITU BROMODEOXYURIDINE LABELING
037
20666317875 1988 CANCER 62 (4): 740-748
CHO KG; DEARMOND SJ; BARNWELL S; EDWARDS MSB; HOSHINO T
PROLIFERATIVE CHARACTERISTICS OF INTRACRANIAL AND SPINAL TUMORS OF DEVELOPMENTAL ORIGIN
17
20677288286 1990 CANCER 66 (1): 30-34
KERSH CR; CONSTABLE WC; SPAULDING CA; HAHN SS; ANDERSEN WA; et al.
A PHASE-I-II TRIAL OF MULTIMODALITY MANAGEMENT OF BULKY GYNECOLOGIC MALIGNANCY - COMBINED CHEMORADIOSENSITIZATION AND RADIOTHERAPY
020
20681269334 1996 CANCER 78 (4): 827-833
Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; et al.
The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract
010
20691499477 1997 CANCER 80 (8): 1472-1481
Popov Z; Hoznek A; Colombel M; BastujiGarin S; LefrereBelda MA; et al.
The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder
058
207028758842 1993 CANCER AND METASTASIS REVIEWS 12 (2): 83-101
ROSS D; SIEGEL D; BEALL H; PRAKASH AS; MULCAHY RT; et al.
DT-DIAPHORASE IN ACTIVATION AND DETOXIFICATION OF QUINONES - BIOREDUCTIVE ACTIVATION OF MITOMYCIN-C
12122
#LCRNCRNode / Date / Journal / AuthorLCSGCS
207135628843 1993 CANCER AND METASTASIS REVIEWS 12 (2): 165-176
ROCKWELL S; SARTORELLI AC; TOMASZ M; KENNEDY KA
CELLULAR PHARMACOLOGY OF QUINONE BIOREDUCTIVE ALKYLATING-AGENTS
340
20729295269 1979 CANCER BIOCHEMISTRY BIOPHYSICS 3 (3): 129-134
BIAGINI RE; PARDINI RS; LIN AJ; SARTORELLI AC
EFFECTS OF THE BIOREDUCTIVE ALKYLATING AGENT 2,3-BIS(CHLOROMETHYL)-1,4-NAPHTHOQUINONE ON COUPLED MITOCHONDRIA ISOLATED FROM SARCOMA 180 ASCITES-CELLS
36
20732178085 1989 CANCER BIOCHEMISTRY BIOPHYSICS 10 (4): 337-343
SCHOENBERGER OL; BEIKIRCH S
CELL-CYCLE PHASES OF 2 HUMAN-LUNG TUMOR-CELL LINES DERIVED FROM SQUAMOUS-CELL CARCINOMA AND PULMONARY METASTASIS OF A RHABDOMYOSARCOMA (HS-24 AND HS-57) AND NORMAL-ACETYLALANINE AMINOPEPTIDASE ACTIVITY
00
207411508287 1990 CANCER BIOCHEMISTRY BIOPHYSICS 11 (4): 275-287
MUKHERJEE U; BASAK J; CHATTERJEE SN
DNA DAMAGE AND CELL KILLING BY NITROFURANTOIN IN RELATION TO ITS CARCINOGENIC POTENTIAL
28
20751448288 1990 CANCER CELLS-A MONTHLY REVIEW 2 (3): 79-83
SKANDALIS A; GLICKMAN BW
ENDOGENOUS GENE SYSTEMS FOR THE STUDY OF MUTATIONAL SPECIFICITY IN MAMMALIAN-CELLS
013
20762904962 1978 CANCER CHEMOTHERAPY AND PHARMACOLOGY 1 (2): 83-90
DAVIS HL; HOFF DDV; HENNEY JE; ROZENCWEIG M
ROLE OF ANTI-TUMOR ANTIBIOTICS IN CURRENT ONCOLOGIC PRACTICE
114
20774184963 1978 CANCER CHEMOTHERAPY AND PHARMACOLOGY 1 (4): 243-247
CONTRERAS A; SANCHEZPEREZ RM; ALONSO G
HALOMETHYL-1,2,3-TRIAZOLE DERIVATIVES - NEW TYPE OF ALKYLATING AGENT ACTIVE IN MOUSE TRANSPLANTABLE TUMORS
014
2078302485270 1979 CANCER CHEMOTHERAPY AND PHARMACOLOGY 3 (3): 143-160
VIG BK
MUTAGENIC EFFECTS OF SOME ANTI-CANCER ANTIBIOTICS
019
207921175943 1981 CANCER CHEMOTHERAPY AND PHARMACOLOGY 6 (1): 1-9
POWIS G; AMES MM; KOVACH JS
DOSE-DEPENDENT PHARMACOKINETICS AND CANCER-CHEMOTHERAPY
027
208012417876 1988 CANCER CHEMOTHERAPY AND PHARMACOLOGY 22 (2): 126-130
SCHLAGER JJ; POWIS G
MITOMYCIN-C IS NOT METABOLIZED BY BUT IS AN INHIBITOR OF HUMAN-KIDNEY NAD(P)H-(QUINONE-ACCEPTOR)OXIDOREDUCTASE
1949
#LCRNCRNode / Date / Journal / AuthorLCSGCS
20817438086 1989 CANCER CHEMOTHERAPY AND PHARMACOLOGY 23: S68-S73
ENSMINGER W
HEPATIC ARTERIAL CHEMOTHERAPY FOR PRIMARY AND METASTATIC LIVER CANCERS
012
208215288087 1989 CANCER CHEMOTHERAPY AND PHARMACOLOGY 25 (1): 45-50
MAYBAUM J; HAFNER MS; BURTON EC; STETSON PL; ENSMINGER WD; et al.
RESPONSE OF HUMAN HT-29 COLORECTAL TUMOR-CELLS TO EXTENDED EXPOSURE TO BROMODEOXYURIDINE
14
208317348289 1990 CANCER CHEMOTHERAPY AND PHARMACOLOGY 27 (3): 187-193
PAN SS
PORFIROMYCIN DISPOSITION IN OXYGEN-MODULATED P388 CELLS
1319
20845178479 1991 CANCER CHEMOTHERAPY AND PHARMACOLOGY 28 (3): 228-230
GUSTAFSON DL; PRITSOS CA
INHIBITION OF MITOMYCIN-C AEROBIC TOXICITY BY THE SELENOORGANIC ANTIOXIDANT PZ-51
17
20858408658 1992 CANCER CHEMOTHERAPY AND PHARMACOLOGY 29 (4): 290-296
GHIORGHIS A; TALEBIAN A; CLARKE R
INVITRO ANTINEOPLASTIC ACTIVITY OF C7-SUBSTITUTED MITOMYCIN-C ANALOGS MC-77 AND MC-62 AGAINST HUMAN BREAST-CANCER CELL-LINES
01
20861279020 1994 CANCER CHEMOTHERAPY AND PHARMACOLOGY 33 (4): 291-297
MATSUNAGA H; KATANO M; SAITA T; YAMAMOTO H; MORI M
POTENTIATION OF CYTOTOXICITY OF MITOMYCIN-C BY A POLYACETYLENIC ALCOHOL, PANAXYTRIOL
021
208713229169 1995 CANCER CHEMOTHERAPY AND PHARMACOLOGY 35 (4): 318-322
CHIRREY L; CUMMINGS J; HALBERT GW; SMYTH JF
CONVERSION OF MITOMYCIN-C TO 2,7-DIAMINOMITOSENE AND 10-DECARBAMOYL 2,7-DIAMINOMITOSENE IN TUMOR-TISSUE IN-VIVO
917
20885279478 1997 CANCER CHEMOTHERAPY AND PHARMACOLOGY 40 (6): 463-468
Chelladurai M; Lobocki CA; Sultani M; Hanna Y; Drelichman A; et al.
Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil
14
20893519948 2003 CANCER CHEMOTHERAPY AND PHARMACOLOGY 52 (4): 325-332
Ostruszka LJ; Shewach DS
The role of DNA synthesis inhibition in the cytotoxicity of 2 ',2 '- difluoro-2 '-deoxycytidine
03
2090040292 1960 CANCER CHEMOTHERAPY REPORTS (6): 29-36
WELCH AD; PRUSOFF WH
A SYNOPSIS OF RECENT INVESTIGATIONS OF 5-IODO-2'-DEOXYURIDINE
310
#LCRNCRNode / Date / Journal / AuthorLCSGCS
2091172293 1960 CANCER CHEMOTHERAPY REPORTS (6): 94-114
[Anon]
5-FLUOROURACIL AND ITS RIBOSIDES
00
20921122294 1960 CANCER CHEMOTHERAPY REPORTS (7): 65-86
DUVALL LR
AZASERINE
11
2093158295 1960 CANCER CHEMOTHERAPY REPORTS (7): 86-98
DUVALL LR
6-DIAZO-5-OXO-L-NORLEUCINE
12
2094136296 1960 CANCER CHEMOTHERAPY REPORTS (8): 156-175
DUVALL LR
TRIS(1-AZIRIDINYL)PHOSPHINE OXIDE (TEPA)
01
2095822362 1961 CANCER CHEMOTHERAPY REPORTS (11): 51-56
GREENBERG J; MANDELL JD; WOODY PL
A PRELIMINARY REPORT - RESISTANCE AND CROSS-RESISTANCE OF ESCHERICHIA-COLI MUTANTS TO RADIOMIMETIC AGENTS
01
2096718363 1961 CANCER CHEMOTHERAPY REPORTS (11): 87-89
SZYBALSKI W; SZYBALSKA EH
A NEW CHEMOTHERAPEUTIC PRINCIPLE FOR THE TREATMENT OF DRUG-RESISTANT NEOPLASMS
00
20971154364 1961 CANCER CHEMOTHERAPY REPORTS (11): 177-237
[Anon]
DATA SUMMARIES OF SELECTED PURINE ANTAGONISTS
00
2098116365 1961 CANCER CHEMOTHERAPY REPORTS (14): 174-179
DUVALL LR
ROSS AZO MUSTARD
00
2099162127 1970 CANCER CHEMOTHERAPY REPORTS PART 1 54 (3): 195-&
WHITTING.RM; CLOSE HP
CLINICAL EXPERIENCE WITH MITOMYCIN C (NSC-26980)
057
2100282128 1970 CANCER CHEMOTHERAPY REPORTS PART 1 54 (4): 283-&
SUTOW WW; FERNBACH DJ; THURMAN WG; HOLTON CP; WATKINS WL
DAUNOMYCIN (NSC-82151) IN TREATMENT OF METASTATIC NEUROBLASTOMA
09

Page 21 of 102:  1   11  [  21  22  23  24  25  26  27  28  29  30 ]  31   41   51   61   71   81   91  |  101 
Generated by: HistCite 2005.08.29